66P - Efficacy and safety of nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): Updated results of the ongoing non-interventional study (NIS) VARGADO (NCT02392455)

Autor:	Grohe, C., Gleiber, W., Krüger, S., Mueller-Huesmann, H., Schulze, M., Atz, J., Kaiser, R.
Zdroj:	In Annals of Oncology December 2019 30 Supplement 11:xi24-xi24
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu